CORITON Completes U.S. FDA Annual Enterprise Registration Fee Payment for Fiscal Year 2025

On December 6, 2024, CORITON announced that it has successfully completed the payment of the U.S. Food and Drug Administration (FDA) annual enterprise registration fee for fiscal year 2025. This move marks CORITON's determination to continue to delve into the U.S. medical cart market and demonstrates the company's firm commitment to long-term investment in the U.S. market in a complex and ever-changing international economic environment. As a company that has been deeply involved in the U.S. medical cart market for nearly 10 years, CORITON has won widespread customer recognition and market share from global customers with its high-quality products and excellent services. It has become the only Chinese medical cart company currently registered in the EU, the United States, and the United Kingdom. However…

Background

CORITON: On December 6, 2024, CORITON announced that it has successfully completed the payment of annual corporate registration fees for the 2025 fiscal year of the U.S. Food and Drug Administration (FDA). This move marks CORITON's determination to continue to delve into the U.S. medical cart market and demonstrates the company's firm commitment to long-term investment in the U.S. market in a complex and ever-changing international economic environment. As a company that has been deeply involved in the U.S. medical cart market for nearly 10 years…

On December 6, 2024, CORITON announced that it has successfully completed the payment of annual corporate registration fees for the U.S. Food and Drug Administration (FDA) for fiscal year 2025.

This move marks CORITON's determination to continue to delve into the U.S. medical cart market, and demonstrates the company's firm commitment to long-term investment in the U.S. market under the complex and ever-changing international economic environment.

Key information

• CORITON: On December 6, 2024, CORITON announced that it has successfully completed the payment of annual corporate registration fees for the 2025 fiscal year of the U.S. Food and Drug Administration (FDA). This move marks CORITON's determination to continue to delve into the U.S. medical cart market and demonstrates the company's firm commitment to long-term investment in the U.S. market in a complex and ever-changing international economic environment. As a company that has been deeply involved in the U.S. medical cart market for nearly 10 years…
• On December 6, 2024, CORITON announced that it has successfully completed the payment of annual corporate registration fees for the U.S. Food and Drug Administration (FDA) for fiscal year 2025.
• This move marks CORITON's determination to continue to delve into the U.S. medical cart market, and demonstrates the company's firm commitment to long-term investment in the U.S. market under the complex and ever-changing international economic environment.

What this means for medical device customers

It reflects CORITON's ongoing work in medical trolley design, quality management, compliance documentation, global service and practical customer support.

FAQ

Who should read this update?

Medical device manufacturers, distributors, OEM project teams, hospital procurement teams and partners evaluating medical carts, mounting systems or regulatory support from CORITON.

Why is this relevant to CORITON customers?

It reflects CORITON's ongoing work in medical trolley design, quality management, compliance documentation, global service and practical customer support.

News Code: KRT-N-5140